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ABSTRACT OF THESIS

PEPTIDE DEFORMYLASE:
A MODELING STUDY OF THE ACTIVE SITES OF PLANTS AND BACTERIA
AND THE DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY ANALYSIS OF
PEPTIDE-BASED INHIBITORS

All nascent polypeptides synthesized in bacteria, mitochondria, or chloroplasts
start with a N-formylmethionine. Peptide deformylase (PDF) is a mononuclear metal ion
protein that is responsible for removing the N-formyl group of nascent proteins found in
bacteria and chloroplasts in order for them to become mature proteins. It is possible, as
seen from the literature with actinonin, to chelate the enzyme’s metal ion and inhibit the
function of protein production essentially resulting in death of the bacteria, or plant. This
study examines the active site of Arabidopsis thaliana (At) types of PDF (AtDEF1 and
AtDEF2, respectively) as well as bacterial DEF2 using sequence alignments and
computational modeling. This work also investigates the biological efficacy of designing
and synthesizing inhibitors that mimic actinonin or the D1 substrate that will halt, or
severely retard, the activity of the PDF enzyme in vitro and in vivo. Through this
research, we were able to determine specific residues that were conserved amongst the
plant DEF2 sequences that were present less than 20% of the time in plant DEF1 and
bacteria DEF2. This data allowed us to hypothesize plant DEF2’s substrate specificity as
well as a possible design that is selective towards plants and not bacteria. Also, based on
preliminary results, the novel thiol-actinonin chimera that was synthesized showed
inhibition activity of AtDEF2 during in vitro enzyme assays.
KEYWORDS: Peptide deformylase, N-formylmethionine, DEF2, Arabidopsis thaliana,
Actinonin.
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Chapter 1: Introduction to Peptide Deformylase (PDF)
1.1 Initial Discovery and Studies of PDF
Peptide Deformylase (PDF) was first investigated in the late 1960’s by Jerry M.
Adams at Harvard University. By incubating formyl-Met-Ala-Ser (fMAS) peptide with
dialyzed extracts from Escherichia coli and Bacillus stearothermophilus, Adams
observed, via electrophoresis experiments in conjunction with ninhydrin quantification
methodology, that the formyl groups of formylmethionyl peptides were cleaved resulting
in the methionyl peptides.1 He entitled the enzyme peptide deformylase that was
responsible for the activity observed. Adams went even further to show, by using
homologues of fMAS, that there existed an enzyme activity that was responsible for the
further cleavage of the methionine residue; aptly entitled methionine aminopeptidase
(MAP).1 Adams hypothesized that MAP was selective in the methionyl proteins it would
cleave based on the residue that was adjacent to the aminoterminal methionine.
Many years later, in the mid 1980’s, Fred Sherman, John Stewart, and Susumu
Tsunasawa performed a study that supported Adams’ hypothesis. They showed that
MAP would only cleave the aminoterminal methionine if it were present adjacent to one
of the following residues: alanine, cysteine, glycine, proline, serine, threonine, and
valine.2 In contrast, MAP would not cleave the terminal methionine if it were directly
adjacent to the residues arginine, asparagine, aspartic acid, glutamine, glutamic acid,
isoleucine, leucine, lysine, or methionine.2 They suggested that the size of the adjacent
residue’s side chain had to have a radius of gyration of 1.29Å or less in order for the
MAP enzyme to successfully complete the synthesis of the resultant protein.2
However, Adams’ main efforts involved the study of PDF and not MAP. His
attempts to stabilize the enzyme PDF were difficult at best due to what we now know is
oxidation of the iron cation at the enzyme’s center.3 In his attempts to stabilize the
enzyme (pH, buffer and ionic strengths, EDTA, etc.) he used a range of thiols that were
commonly used for protein synthesis. The usage of the various thiols produced an
interesting result as seen in (Table 1.1).1 Essentially, the thiols were in the concentration
range of 0-6 mM in the extracts, which for some of the thiols was sufficient to reduce the
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enzyme’s activity to negligible percentages.1 This loss in enzyme activity via the
engagement of thiols will prove useful for inhibitor design, which is discussed later.
The basic biological function of the PDF enzyme, in regards to the line of steps
post-translation, is to remove the formyl group that is placed on all plant protein
sequences. This is done so the synthesized protein can be “marked” accordingly after the
removal of the terminal methionine. The “marker” can be any number of posttranslational modifications like hydroxylation, or methylation, etc. The “marker” is then
recognized by other proteins that are responsible for the transportation of the mature
protein to the appropriate location within the cell. Without this universal initiation step,
the N-terminus formyl group on all proteins would remain, and the protein would be
degraded and recycled resulting in overall plant death.
Table 1.1: Percent Activity of PDF When Incubated with Certain Thiols1
Thiol

Concentration (mM) Percent Activity of an Undialyzed Extract

None

0.0

95.0

β-Mercaptoethanol

6.0

5.0

Reduced Glutathione

6.0

5.0

Cysteine

6.0

<2.0

Oxidized Glutathione 3.0

25.0

Further studies of the enzyme Peptide deformylase have shown it to be a
mononuclear metal ion protein. In the early 1990’s, the metal cation at the heart of PDF
was believed to be Zn2+ based on structural similarities observed to metalloproteases
found in the zinc metalloprotease family. However, the enzyme appeared to have a low
activity of 0.8 U/mg against the fMAS substrate.4,5 However, Dehua Pei’s group at Ohio
State University was able to increase this activity to 220 U/mg for the zinc-containing
enzyme using bacterial overproduced purified enzyme preparations.6 A few years later,
during the mid-1990’s, Groche and Wagner et al. were able to determine that PDF was
actually an Fe2+ enzyme with a specific activity of 1200 U/mg and that Ni2+ also showed
high activity figures relative to the iron-containing enzyme.7,8,9 The purification was
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accomplished for the labile iron-containing PDF by using catalse as a stabilizing agent
against oxidation during the purification procedure.7,8,9
Studies by Meinnel and Blanquet have provided evidence that certain sequences
relative to the PDF active site are conserved throughout the bacterial form of PDF.10 In
their study they aligned nine bacterial PDF sequences. Their original contention for zinc
to be the metal cation at the core of the enzyme was based on the signature sequence
HEXXH (histidine, glutamic acid, any amino acid, any amino acid, histidine) found near
the active site, which is found in the zinc metalloprotease family.10 They also noticed
another conserved sequence of amino acids, EGCLS (glutamic acid, glycine, cysteine,
leucine, serine) near the active site. A third and final conserved sequence was recognized
also. That sequence was found to be GXGXAAXQ (glycine, any amino acid, glycine,
any amino acid, alanine, alanine, any amino acid, and glutamine).10 Through this study,
and that of Becker and Wagner et al., it was gleaned that the two histidines in the
HEXXH conserved sequence bind to the metal ion, as does the cysteine from the
conserved sequence EGCLS and a water molecule.10,11 Hence, the metal ion in the PDF
enzyme is tetrahedrally coordinated. Similar instances of conserved sequences of
residues near the active site are observed with plant AtDEF1 and AtDEF2 (Arabidopsis
thaliana PDF types 1 and 2, respectively) and will be discussed in further detail later in
the text.

1.2 Actinonin: The Gold Standard in PDF Inhibition
1.2.1 Initial Structural Constitution of Actinonin
Actinonin 1 (Figure 1.1) was initially isolated from a Malayan strain of
Actinomyces by R. Green and R. Bhagwan Singh.12 Green and Singh systematically
screened soil and other materials to find microorganisms that possessed antibiotic
properties. They found a new species of actinomycete that proved active against a
number of bacterial strains. Gordon et al. were able to devise a procedure for the
cultivation of the organism and for the isolation of the active ingredient, actinonin, in the
early 1960’s.12 Upon testing actinonin against several Gram-positive and Gram-negative
bacteria, Gordon and his colleagues observed the compound possessed great antibiotic
properties.13 They observed the melting point of actinonin to be 148° and the formula to

3

be C19H35N3O5 via compositional analysis and high resolution mass spectrometry.13 The
compositional analysis included extensive hydrolysis of actinonin using hydrochloric
acid, derivative tests, and NMR and MS studies.
The results of the analysis yielded the conclusion that actinonin was comprised of
D-pentylsuccinic

acid, L-valine, L-prolinol, and hydroxylamine with the depletion of three

water molecules.13 This composition was intriguing because most polypeptide antibiotics
known at the time were made of D-amino acid residues.14 The structure of actinonin
(Figure 1.1) contains only L-amino acid residues.

O
H
N

N
N
H

OH

O
HO

O

1

Figure 1.1: Structure of Actinonin 1.
1.2.2 Total Synthesis of Actinonin/Analogues via the Isomaleimide
Methodology
Based on the constitution studies of actinonin discussed earlier, Anderson et al.
were able to devise a synthesis involving the coupling of L-valyl-L-prolinol (2) and a
derivative of pentylmaleic anhydride 3 (Scheme 1.1).15
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Scheme 1.1: Coupling of L-valyl-L-prolinol (2) and Pentylmaleic Anhydride
Derivative 3.
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O
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O
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Actinonin

In order to synthesize 2, Anderson et al. started with reduction of L-2ethoxycarbonyl-5-pyrrolidone (6) via lithium aluminum hydride (LAH) in anhydrous
ether followed by continuous extraction for 24 hrs to obtain L-prolinol (7).15 Then, 7 and
the valine-derived ester 8 were coupled in ethyl acetate at room temperature to yield the
dipeptide product 9.15 Finally, 9 was reduced to 2 via catalytic hydrogenation with 10%
palladium-charcoal to form the carbamic acid intermediate 10 and subsequent thermal
decarboxylation yielded 2 (Scheme 1.2).15
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Scheme 1.2: Synthesis of L-Valyl-L-Prolinol (2).
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Initially, Anderson, et al., believed that the synthesis could be accomplished using
pentylsuccinic anhydride 10 reacted with O-benzylhydroxylamine (12) to produce the
pentylsuccinamic acid derivative 13 (Scheme 1.3).15 They later decided to use
pentylmaleic anhydride 11 to produce the pentylmaleamic acid derivative 14 instead
because they believed there would be more selectivity for the carbonyl group which is
remote from the alkyl substituent in 11 (Scheme 1.3).15 However, by choosing the maleic
anhydride route over the succinic anhydride route, they would have to eventually
hydrogenate the double bond.
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Scheme 1.3: Synthesis of Maleamic Acid 14: Pentylsuccinic Anhydride 10 and
Pentylmaleic Anhydride 11 Reacted with O-benzylhydroxylamine (12) to give the
Corresponding Acids 13 and 14, respectively. The arrow on 11 indicates the preferred
carbonyl group by nucleophilic amines.
O

C5H11

H2N
O

12

Ph
HO2C

O

O
HN

C5H11

O
O

10

13
Ph
Not Synthesized

O

C5H11

H2N
O

O

Ph

12

HO2C

O
HN

C5H11

O
O

14

11

Ph

Next, Anderson et al. dehydrated 14 using N, N'-dicyclohexylcarbodiimide (DCC)
to obtain the desired isomaleimide 3 and the maleimide 16 isomers (Scheme 1.4). The
successful completion of these products was determined using ozonolysis reactions and
identifying the resultant 2,4-dinitrophenylhydrazones.15
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Scheme 1.4: Dehydration of 14 to Produce Isomaleimide 3 and Maleimide 16
Derivatives.
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Next, Anderson et al. reacted 3 with 2 to produce O-benzyldidehydroactinonin (4)
(Scheme 1.1).15. After catalytic hydrogenation of 4 and purification of the diastereomers
of actinonin 5, the antibiotic actinonin 1 was obtained.15

Scheme 1.1: Coupling of L-valyl-L-prolinol (2) and Pentylmaleic Anhydride
Derivative 3.
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This isomaleimide methodology was applied to form analogues of actinonin.
These analogues were made by replacing the L-prolinol, L-valine, or D-pentylsuccinic
acid residues with pyrrolidine, alanine, or succinic acid residues, respectively, while
keeping the hydroxamic acid chelating fragment constant.15

1.2.3 Survey of Other Methodologies Used for the Synthesis of
Actinonin Analogues
During the initial studies of actinonin, it was observed that even though it showed
antibiotic characteristics with various bacteria it also caused the fast appearance of
9

resistant strains to the compound.16 With this in mind, Anderson, Devlin, et al., decided
to synthesize analogues of actinonin in hopes of competing with the resistant strains.16
The main similarity between all of these analogues is that they maintain the hydroxamic
acid chelating group found in actinonin. The other residues found in the backbone of
actinonin, such as the L-prolinol, L-valyl, and D-pentylsuccinic acid residues, are varied.
The various methods include the already discussed isomaleimide route15, the
anhydride-imide method16, the mixed anhydride method17, the anhydride-ester route18,
and the dicyclohexylcarbodiimide (DCC) coupling reactions19. Basically, all of the
anhydride routes involve anhydro-derivative ring cleavage due to nucleophilic attack by
an amido-amine.19 Synthetically, the isomaleimide and anhydride-imide methodologies
are useful because they lead to the side chain closest to the hydroxamic acid group (Rd, a
pentyl hydrocarbon side chain in actinonin) having a β-position 17 relative to the
hydroxamic acid residue (Figure 1.2).18
O

Rd
H
N

Ra

O



OH

N

N
H

Rb

Rc

O

17
Figure 1.2: Actinonin Backbone; Rd is ß to the hydroxamic acid residue.18
The anhydride-ester methodology is synthetically useful because it affords an α-relation
18 of the Rd side chain to the hydroxamic acid residue to produce other actinonin
analogues (Figure 1.3).18
O

O
H
N

Ra

OH



N
Rb

Rc

O

N
H

Rd

18
Figure 1.3: Actinonin Backbone; Rd is α to the hydroxamic acid residue.18
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The DCC coupling reactions are of significant importance for three reasons. First,
this was the first ever reported usage of the reagent DCC to form amide bonds from
amino-amides and esters of dicarboxylic acids.19 Secondly, this synthetic route allowed
for the amide bonds to be formed without having to cleave a ring via nucleophilic attack
on cyclic anhydro-derivatives, as was the case with the isomaleimide, anhydride-imide,
and anhydride-ester methodologies.19 Finally, this coupling methodology proved highly
effective in the synthesis of my chimera of actinonin and an existing sulfhydryl, which
will be discussed further in Chapter 3.

1.2.4 Actinonin’s Inhibitory Effect on Bacterial PDFs
Due to the increase in pathogenic bacteria that are resistant to current antibiotics,
a search has evolved over the last several years to find a new, selective target common to
all bacteria that doesn’t affect mammals.20 Peptide deformylase serves as an ideal target
due to its ubiquity throughout the bacterial spectrum, its importance to the
microorganism, and its low functionality in mammalian cells. In 2000, Chen et al.
showed that the naturally occurring actinonin 1 served as a potent, reversibly specific
inhibitor of the enzyme peptide deformylase.20 Also, at the time of Chen’s publication,
there were no known inhibitors reported that inhibited protein modification after
translation.20
In order to prove actinonin’s specificity for the enzyme peptide deformylase,
Chen et al. started with dose-dependent studies comparing the level of actinonin
concentration vs. PDF activity. They discovered that for Ni-PDF, the IC50 values (50%
inhibitory concentration) approached approximately 50% of the concentration of the
enzyme used, suggesting that actinonin is bound very tightly by PDF and the IC50
changed when the enzyme concentration changed.20
To further confirm actinonin’s specificity for PDF, Chen et al. used the arabinose
promoter PBAD-def of E. coli tolC to control the level of expression of deformylase by
regulating the amount of inducer (arabinose) present.20 The more arabinose present, the
more expression of the deformylase gene, and vice versa. When the arabinose level was
made low, the def genes became underexpressed and the PDF enzyme became more
vulnerable to inhibitors specific to PDF.20 Conversely, when the gene was
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overexpressed, one would expect an increase in the minimum inhibitory concentration
(MIC) of the inhibitor.20 Over a range of arabinose levels, only actinonin showed a
relationship between the arabinose inducer concentration and the MIC.20 To further
support the claim of specificity of actinonin for PDF, the other inhibitors used
(fosfomycin and ciprofloxacin) showed no relationship to the inducer concentration
levels and maintained the same MIC throughout.20 Even after altering another PBAD-def
gene that was not dependent on the arabinose concentration, there existed a similar
relationship between the two PBAD-def strains for the enzyme’s susceptibility to
actinonin.20 This data supports the theory that actinonin is PDF specific.
In using Zn-PDF, Chen et al. discovered that the IC50 values were the same
regardless of the incubation time, which ranged from 10 minutes to 100 minutes.20 This
further supports that actinonin is a fast, tight binding inhibitor. Again using the Zn-PDF,
no PDF activity was observed in the presence of actinonin. After dialysis of the samples
for 48 hrs, which removes any free actinonin, the PDF activity was restored to that of the
control sample, showing actinonin is a reversible inhibitor. 20
Chen et al. concluded that actinonin was a competitive, reversible, tight-binding
inhibitor with a chelating hydroxamic acid group. Based on their results, and modeling
studies not yet mentioned, they suggested that analogues of actinonin would be the best
possible route to new antibiotics.20 Not only was the production of analogues important
because of the emergence of resistant strains, but also because their in vivo studies with
actinonin showed a lack of potency. This lack of potency was later shown by Williams et
al. to be due to the metabolic reduction and hydrolysis of the hydroxamate group.26

1.3 Actinonin: Chloroplast-Localized Plant PDF Inhibition
1.3.1 Eukaryotic Homologues: PDF in Arabidopsis thaliana
Hanson in 200021 hypothesized the importance of the enzyme peptide
deformylase in plant plastids. Williams and Houtz in 200022, 23 hypothesized that the
enzyme peptide deformylase would also play a vital role in protein production in plants,
as had been the case for bacteria. Williams et al. 22 identified two types of PDF enzymes
in plants that were essentially eukaryotic homologues of the more familiar bacterial
(prokaryotic) deformylase. Using bacterially expressed Arabidopsis thaliana (At)
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deformylases, Dirk et al. 23 compared the activity of the two plant versions of PDF,
AtDEF1 and AtDEF2, by doing in vitro enzyme assays, in vivo studies involving the
imbibing of Arabidopsis seeds, and direct topical application to leaves of Arabidopsis
plants.
The in vitro enzyme assays consisted of a buffer solution containing bacterially
processed AtDEF2, actinonin, and an N-formyl-Met-Leu-ρ-NA substrate. The cleavage
of the formyl group on the substrate caused the release of the para-nitroaniline group,
which was spectrophotometrically observed at 405 nm. The assays of AtDEF1 and
AtDEF2 with varying concentrations of actinonin showed comparable inhibitory results
to that of the bacterial PDF-actinonin analyses.23 For example, the IC50 for AtDEF2 was
a concentration slightly less than 100 nM of actinonin, while the concentration to
decrease the enzyme’s activity to virtually zero was 300 nM of actinonin.23 Due to
enzyme activity detection limitations, a higher concentration of AtDEF1 was needed
relative to AtDEF2, which subsequently led to the results indicating an almost 2-fold
weaker binding affinity between actinonin and AtDEF1.23
The in vivo seed germination tests of Arabidopsis required the concoction of an
agar medium with actinonin from which the seeds would derive the proper nutrients and
uptake the inhibitor.23 Varying concentrations of actinonin were used to properly analyze
the inhibition of growth over the course of a week. The seeds that were grown from a
medium containing no actinonin served as the controls, while concentrations of 0.81, 1.6,
and 3.2 mM of actinonin served as the variables (Figure 1.4).23 After 5 days, the
actinonin concentration of 0.81 mM allowed normal cotyledon expansion from the
Arabidopsis seeds, but there was no green color due to the lack of chloroplast production.
Actinonin concentration at 1.6 mM hindered the spread of the cotyledons. Finally, the
actinonin at 3.2 mM allowed only a slight emergence of the radicale and nothing further.
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Figure 1.4: Actinonin treatment of Arabidopsis.23
Direct topical application of actinonin/detergent aqueous solutions to the leaves of
Arabidopsis plants induced a retardation of growth and slow bleaching.23 After a week of
applications, the size and rate of growth of treated leaves was substantially inhibited, and
loss of color, or bleaching, was observed.

1.3.1.1 D1 Specificity of PDF in Arabidopsis thaliana
Using peptide mimics of certain chloroplast-translated proteins, Dirk et al. in
200224 investigated AtDEF2’s substrate specificity based on enzymatic assay analysis and
establishing kinetic rates for each mimic to determine adjacent residue effects. One of
the more important peptide mimics that was studied was based on the D1 protein. The
D1 protein is part of the photosystem II (PS-II) reaction center located in the thylakoid
membrane, so any inhibition of the AtDEF2 enzyme would interfere with the complete
processing of the D1 protein and hence affect the outcome of the absolutely vital PS-II
process.24 It turns out that the D1 substrate mimic had the highest enzymatic activity
recorded of all the mimics studied, indicating the AtDEF2 enzyme’s preference for this
particular sequence. For the enzyme assays, AtDEF2 was mixed with various chloroplast
peptide analogues, and, using a spectrophotometer at a wavelength of 340 nm, the
amount of NADH was observed. The more NADH present, the more processed a
particular peptide mimic; hence a higher affinity of the substrate to bind to the PDF
enzyme.
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1.3.2 PDF Inhibition in Nicotiana tabacum and Reduction of D1
Protein
Apparently tobacco plants are not as susceptible to actinonin as are Arabidopsis
and pea plants. At inhibitor concentrations where pea and Arabidopsis plants would
bleach and die, the tobacco plants showed only stunting and some bleaching.25 A study
performed by Hou et al. in 200425 showed that by monitoring the quantum efficiency of
chlorophyll fluorescence in plants, one is able to ascertain the effect of actinonin on
photosystem II (PS-II) activity. It was observed that after five days of painting of the
tobacco plant leaves, the PS-II activity had virtually ceased, but the plants did not bleach
as did the pea and Arabidopsis plants..25 The decrease in PS-II activity was attributed to
a decrease in the level of D1 protein and hence the subsequent cessation of PS-II
function. By not processing the N-formyl methionine portion of the D1 protein, one is
able to block the production of the high-demand protein monomer, which is responsible
for the reassembly of any disassembled PS-II complexes, thereby causing the death of the
plant due to a lack of photosynthetic production.25

1.4 The Metabolism of Actinonin
Because actinonin 1 is capable of inhibiting PDF in many different types of plants
(as evidenced by in vitro enzyme assays) and different types of plant seeds (as evidenced
by in vivo seed germination tests), it was hoped that it could be used as a broad-spectrum
herbicide.26 This hope, however, turned out to be empty, due to the reduction and
hydrolysis of the hydroxamate group to the resultant carboxylic acid 20 and amide 19
seen during in vivo plant studies and in vitro microsomal fraction analysis (Scheme
1.5).26 According to Hou, et al.26 tobacco plants are capable of absorbing and
metabolizing all but 17% of the initially applied actinonin after 48 hours. They were able
to isolate the two metabolites via reverse-phase HPLC and determine their formula based
on mass spectrometric experiments (Figure 1.5).26 They tested the metabolites’ inhibition
activity and showed they had relatively little effect on the DEF2 enzyme when compared
to unmetabolized actinonin.26 It is this effect that makes the search for nonmetabolyzable
analogues of actinonin of considerable interest.
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Scheme 1.5: In Vivo Reduction and Hydrolysis of Actinonin in Plants.
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Figure 1.5: Reverse-Phase HPLC fractionation of actinonin after incubation with
tobacco microsomes.26 (A) Actinonin (40 μM) was incubated with tobacco root microsomal proteins
and aliquots were removed at each time point and analyzed by HPLC. (B) The actinonin peak at 0 h and
the m1 and m2 peaks from 12 h were collected, lyophilized, and reconstituted to volumes equal to those
injected on the HPLC.

17

1.5 Survey of Various Types of PDF Inhibitor Designs
Due to the reduction and hydrolysis of the inhibitor actinonin 1 discussed in
section 1.4 above, a new design is required where the inhibitor will not only fit well in
PDF enzyme active sites and perform well during in vitro assays, but be resistant to
breakdown in vivo. Three main types of inhibitors have been designed. The first are the
analogues of the actinonin molecule retaining the hydroxamic acid group but with altered
side chains (see sections 1.2.2 and 1.2.3).16-19, 20, 27-30 Then there are the thiols, with
sulfhydryls as the chelating group, and using different backbones from that seen in
actinonin.31-33 Finally, came attempts at solving the reduction and hydrolysis issues. In
the third class, the hydroxamate chelating group is rearranged. This is done by reversing
the location of the nitrogen and the N-hydroxyl group to the opposite side of the carbonyl,
creating an aldehyde.34,35 These compounds are discussed later in the text.

1.5.1 Linear Thiol PDF Inhibitor Designs
Huntington et al. in 200032 designed the first series of peptide-based thiols to
serve as inhibitors of recombinant PDF from E. coli and B. subtilis (Scheme 1.6). They
were able to obtain, via in vitro enzyme assays, KI values, which reflected the potency of
each inhibitor against PDF. Their best KI value reported was for one of the thiol
inhibitors, 29b, with a potency of 19 +/- 1 nM. The published synthesis combined an
acetyl-protected thiol-acid 25 and a p-nitroaniline amine 27a-c, to give the final thiol
inhibitor (29a-h) after deprotection (scheme 1.6).32
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Scheme 1.6: Pei’s Synthesis of Peptide-Based Thiol Inhibitors32
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1.5.2 Reverse Hydroxamate Macrocyclic PDF Inhibitor Designs
The macrocyclic ring in the reverse hydroxamate compounds have been shown to
reduce the proteolytic effect experienced in the cell media and increase the selectivity of
peptide-based inhibitors.36, 37 Using compound BB-3497’s 30 (Figure 1.6) backbone, it is
believed that the macrocyclic connection can be made between the P1 and P3 side chains,
which causes an increase in active site binding.34 Hu, et al., in 2003 set out to construct a
macrocyclic reverse hydroxamate peptide-mimetic inhibitor 44 in hopes of solving the
aforementioned hydrolysis and stability issues associated with actinonin (Schemes 1.7
and 1.8).34, 36
P2
O

O
N

H

N

N
H

OH

P1
O

30
P3

Figure 1.6: Structure of BB-3497 30. The P1-3 notations indicate the three common positions of
side chains relative to one another and the chelating group.

Formation of the first precursor 38 of the synthesis34 (Scheme 1.7) involved
starting with a simple commercial acid 31 and attaching a chiral auxiliary 32 in order to
set the stereochemistry of the α-ethyl alcohol side chain in compound 34. From there, the
chiral auxiliary is cleaved and the acid is replaced with O-Benzylamine to form
compound 35. Next, a Mitsunobu reaction34 is carried out to form the 4-membered
lactam 36, which is reopened 37, and the amine is then protected with a formyl group to
give the first precursor 38.
The second precursor 41 and final coupling (Scheme 1.8) started with taking a
simple, commercially available alcohol 39 and converting it to the primary amine 40.
Next, the primary amine 40 was combined with a commercially available leucine amino
acid to form the second precursor 41. Then, the second precursor 41 was coupled with
the first precursor 38 to give the diene 42. From the diene 42, Grubbs’ catalyst was used
20

to do an olefin metathesis reaction to close the ring to give the initial macrocyclic alkene
43. Finally, the macrocyclic alkene 43 was debenzylated and reduced to give the final
macrocyclic inhibitor 44. 34

Scheme 1.7: Synthesis of the First Coupling Precursor 38 of Compound 44.
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Scheme 1.8: Synthesis of the Second Coupling Precursor 41 and Final Coupling to
Produce Compound 44.
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Compound 44’s potency was tested in a dehydrogenase enzyme assay with
Co(II)-PDF (E. coli).6,38 The result was a KI constant of 0.67 +/- 0.2 nM. This data shows
that compound 44 is more than 10-fold more potent than the BB-3497 inhibitor (IC50 = 7
nM) it mimicked.34, 39
Hu et al. in 200435 went even further with their studies of the macrocyclic
inhibitors by experimenting with the ring size. Through synthetic analogue studies, Hu et
al. were able to find that the optimal ring size was 15-17-membered. Also, compared to
the linear peptides of similar backbone, the macrocyclic inhibitors showed an
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approximate 20-fold increase in potency, suffered less proteolytic hydrolysis, and had a
higher selectivity for deformylase over other enzymes.35 The potency of the inhibitors
was very high, with KI* constants in the 0.22-36 nM range when performing Aeromonas
aminopeptidase (AAP) assays, and KI constants in the 11-2100 nM range when
performing dipeptidyl peptidase I (DPPI) assays, with E. coli PDF as the initiater. They
also determined the new macrocyclic inhibitors to be slow-binding, as opposed to the
linear counterparts, which bind quickly.35 With the advent of these new macrocyclic
inhibitors, and taking into account their high potency, the future for the design of
inhibitors seems to prefer this type of scaffolding. For the purposes of plant PDF
inhibition, and especially concerning the more important case of the degradative enzymes
in vivo, the success of such inhibitors remains untested.

1.6 Project Agenda: Computational-Biological Analysis/Synthesis and
Purification
Due to the integral function of the cleaving of the N-formyl group from nascent
proteins post-translation, peptide deformylase is a good target for the development of
antimicrobials and herbicides. The two biggest problems for this development involve
the cross-over that could possibly be experienced when designing an inhibitor for plants
that might also inhibit bacteria as well, and the search for a peptide-based inhibitor that
can fit specifically into the PDF active site, but that can also survive the degradative
enzymes found during in vivo studies.
With the first problem in mind, my collaborative research group proposed an
analysis of the three main types of peptide deformylase: bacterial DEF2, plant DEF2, and
plant DEF1 using computational modeling and alignment software to try to discern
between the bacterial DEF2 and the plant DEF’s. If there exists a difference in the active
sites of the bacterial PDF and the plant PDFs, then one might be able to specifically
design an inhibitor that can knock out plant PDFs and not the bacterial PDF. This would
allow development of a new herbicide that does not adversely affect soil microorganisms.
Overcoming the second problem of interest was hypothesized to be possible if we
could design a novel inhibitor that uses the exact backbone skeleton of actinonin up to the
P1 side chain and then replace the hydroxamate chelating group with a sulfhydryl group.
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By doing this, it was believed the inhibitor would not undergo reduction and hydrolysis
in vivo and at the same time be tightly bound in the active site of PDF because of the
great in vitro success of actinonin observed in earlier studies. This hypothesis was tested
after the synthesis and isolation of a novel thiol-actinonin inhibitor by performing in vitro
enzyme assays, in vivo seed germination analyses, and in vivo topical leaf-painting
experiments. The results showed the chimera to be an inhibitor of AtDEF2 that was ten
times less potent than actinonin (50 nM for actinonin and ~5000 nM for the chimera).
Further studies are necessary in regards to the seed germination tests and the leaf painting
experiments due to the material used at the time being crude.

Copyright © Jonathan C. Barnes 2006
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Chapter 2: Computational Modeling/Analysis of Three Types of PDF Active Sites
2.1 Ligand Interaction Mapping
To begin this project, we wanted to answer the two questions concerning the
comparison of plant DEF2 to both plant DEF1 AND bacterial DEF2. The first question
was why does plant DEF2 prefer certain protein sequences over others, while plant DEF1
showed no great selectivity for any of the protein sequences?24 In addition to the higher
selectivity, plant DEF2 showed a 100-fold higher activity than plant DEF1.24 The second
question was are there enough differences in the active site residues between the bacterial
forms of PDF and the plant forms of PDF? To answer these questions, we started by
compiling a list of interacting ligands of AtDEF2 using the protein data bank and its
PDBSUM utilities.40 Once a master list of interacting residues was constructed, we could
map those particular interacting residues onto the coordinate file of our own crystal
structure of AtDEF2 obtained by Dr. Rodgers (Figure 2.1). The blue region shown in
Figure 2.1 represents the residues in AtDEF2 that interacted with the ligands found in the
database.
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Figure 2.1: Interacting Residues Mapped on AtDEF2. The crystal structure was obtained by
Dr. Rodgers. The blue represents the region of general activity based on the database of ligands and their
specific residue interactions.

2.2 Residue Conservation of the Three Types of PDF
With a general idea of the enzyme’s active site now in hand, the next step was to
identify how many of the residues are conserved. The following alignments of the three
most highly conserved motifs near the active site were performed by Dr. Lynnette Dirk.
The first step in conservational analysis involves performing a technique, known as
BLAST (Basic Local Alignment Search Tool), on the chloroplast length peptide
deformylase protein DNA sequence.43 This was done so that the sequence could be
compared to other sequences in the database and a statistical representation could identify
regions of similarity. Next, the DNA sequences were translated into protein sequences,
and a TargetP prediction was performed .44 This prediction identifies the location of the
N-terminus of the protein sequence for the mature length of the protein. Once the
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location was found, the protein sequence was shortened to isolate that region. After
duplicates and erroneous portions were removed, the remaining protein sequence motifs
were then aligned using CLUSTAL W.45 Finally, the sequences were counted at each
residue position to see what residue each had and if it matched the AtDEF2 sequence.
They all were tallied into the three main motifs of the active site. The definition of
conservation we decided to use was 50% or higher. This meant that at least 50% of the
residues of the other sequences found in the database matched our AtDEF2 residues.
This alignment approach was performed for the AtDEF1 and EcoliDEF2 sequences as
well. This conservational analysis would provide an insight into the more conserved, or
more common, residues found in all plantDEF2’s, plantDEF1’s, and bacteriaDEF2’s,
respectively.

2.2.1 Conservation for AtDEF2
The conservation discussed above was mapped to the enzyme AtDEF2 (Figure
2.2). The blue color in Figure 2.2 represents the conserved residues and the violet color
represents the non-conserved residues. Figure 2.3 represents a ribbons view of the three
conserved motifs of AtDEF2 as well.
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Figure 2.2: Conserved residues for AtDEF2. The conserved residues are in blue and the nonconserved residues are in violet. The blue shading gives a more specific idea of the active site relative to
the general interacting residues shown in Figure 2.1.
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Figure 2.3: Ribbons view of the three conserved motifs of AtDEF2. The yellow, purple,
and blue ribbons represent the three motifs of the active site and the blue ball represents the enzyme’s
central metal.

2.2.2 Conservation for AtDEF1
The conserved residues from the alignment studies discussed above were mapped
onto an AtDEF1 enzyme from the protein data base (Figure 2.4).42 The blue again stands
for conserved residues, while the non-conserved residues are in violet, which cannot be
seen because they are on the opposite side of the enzyme.
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Figure 2.4: Conserved residues of AtDEF1. The blue represents the conserved residues and the
non-conserved residues are in violet, but are not shown because they are on the other side of the enzyme.
42

The blue gives a more specific idea of the enzyme’s active site.

2.2.3 Conservation for E. coli DEF2
The third mapping involved the conserved residues of EcoliDEF2 (Figure 2.5).41
Again the blue represents the conserved residues and the violet represents the nonconserved residues.
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Figure 2.5: Conserved residues of EcoliDEF2. The blue represents the conserved residues and
the non-conserved residues are in violet. The blue provides a more specific idea of the enzyme’s active
site.41

2.3 Comparing plantDEF2’s Conserved Residues with plantDEF1 and
bacteriaDEF2 Residues
Now that we had an idea of what each respective PDF active site looked like, we
could then begin to compare and contrast both the plantDEF1 and the bacteriaDEF2
majority and matching residues with those of plantDEF2 that were conserved. This
provided more insight into how different plantDEF1 and bacteriaDEF2 were from
plantDEF2 and whether or not it would be possible to differentiate between them enough
to design an inhibitor that would be selective only to plantDEF2 and not bacteriaDEF2,
nor plantDEF1. The main point we were looking for was a difference in specific residues
that we could hone in on and take advantage of so we could design an inhibitor specific
to plantDEF2 and not to bacteriaDEF2. In the case of plantDEF2 vs. plantDEF1, we

31

wanted to try and find specific residues that were consistently different between the two
enzymes that might explain plantDEF2’s preference for the D1 photosystem-II protein as
a substrate, while plantDEF1 exhibits no such preference.

2.3.1 Comparison between Plant DEF2 and DEF1
The three motifs of plantDEF2, residues 119-133, 165-178, and 205-219, were
compared with the three motifs of plantDEF1, 45-59, 105-118, and 145-159. More
specifically, we wanted to see if we could find active site residues that were conserved in
plantDEF2 that were not conserved and not the majority residue in plantDEF1 in order to
be able to identify residues that could be used to explain why plantDEF2 prefers the D1
substrate and plantDEF1 does not. Table 2.1 shows this comparison where the red X’s
indicate the low match (20% or less) between plantDEF2’s conserved residues and
plantDEF1’s corresponding residues.

Table 2.1: plantDEF2 vs. plantDEF1. The three motifs of both enzyme’s are compared where
the red X indicates conserved residues in AtDEF2 and the corresponding low matching (20% or less)
residue in AtDEF1, whether or not it was conserved
plantDEF2 vs. plantDEF1
Motif 1: 119-133 (AtDEF2 numbers)
AtDEF1 residue #
AtDEF2 residue#
Conserved DEF2 Residue (50% or higher)
Majority Residue in DEF1 Motif
Number of DEF1 Residues that Matched DEF2
Low Match(20% or less) b/w DEF1 and DEF2

57
58
59
131
132
133
T
D
G
I
G
L
S
A
P
Q
V
G
L(n.c.) N
V
A(31/34) P(33/34) G(32/34) V(27/34) G(31/31) L(31/31) A(31/31) A(31/31) P(31/31) Q(31/31) I(28/31) G(31/31) I(16/32) P(30/33) L(30/34)
T(0)
D(0)
G(32/34) I(0)
G(31/31) L(31/31) S(0)
A(31/31) P(31/31) Q(31/31) V(0)
G(31/31) L(1/32) N(0)
V(0)
NC
X
X
X
X
X
X
X

Motif 2: 165-178 (AtDEF2 numbers)
AtDEF1 residue#
AtDEF2 residue#
Conserved DEF2 Residue (50% or higher)
Majority Residue in DEF1 Motif
Number of DEF1 Residues that Matched DEF2
Low Match(20% or less) b/w DEF1 and DEF2

105
106
107
108
109
110
111
112
113
114
115
116
117
118
165
166
167
168
169
170
171
172
173
174
175
176
177
178
V(n.c.) P(n.c.) F
D(n.c.) E
G
C
L
S
F
P
G
I
Y
A(41/41) L(21/42) F(41/42) F(33/42) E(42/43) G(41/43) C(42/43) L(41/43) S(39/41) V(39/41) D(31/40) G(39/40) F(24/40) R(36/39)
V(0)
P(0)
F(41/42) D(0)
E(42/43) G(41/43) C(42/43) L(41/43) S(39/41) F(0)
P(2/40) G(39/40) I(0)
Y(0)
NC
NC
NC
X
X
X
X

45
119

46
120

47
121

48
122

49
123

50
124

51
125

52
126

53
127

54
128

55
129

56
130

Motif 3: 205-219 (AtDEF2 numbers)
AtDEF1 residue#
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
AtDEF2 residue#
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
Conserved DEF2 Residue (50% or higher)
S(n.c.) L
P
A
R
I(n.c.) F
Q
H
E
Y(n.c.) D
H
L
E(n.c.)
Majority Residue in DEF1 Motif
G(33/35) W(34/35) Q(29/35) A(33/34) R(33/34) I(33/34) L(33/33) Q(32/33) H(32/33) E(31/32) Y(27/31) D(29/30) H(29/30) L(28/29) E(13/29)
Number of DEF1 Residues that Matched DEF2 S(0)
L(0)
P(0)
A(33/34) R(33/34) I(33/34) F(0)
Q(32/33) H(32/33) E(31/32) Y(27/31) D(29/30) H(29/30) L(28/29) E(13/29)
Low Match(20% or less) b/w DEF1 and DEF2 NC
X
X
X
Note: The 'NC' and 'n.c.' in the charts above refer to non-conservation between the AtDEF2 sequence versus the other DEF2 plant sequences.
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One can see there are 14 residues that were conserved in plantDEF2 that hardly showed
up in the database screening for plantDEF1 residues. These specific residues are of keen
interest because they represent consistent differences between the two enzymes. Figures
2.6 (molecular surface) and 2.7 (ribbons) show a pictorial representation of the low
matching residues on the AtDEF2 structure.

Figure 2.6: Low matching residues on AtDEF2. The red represents the low matching residues
found in plantDEF2 when compared to the residues in plantDEF1. Both red and blue represent the
originally conserved residues found in AtDEF2, which were shown as all blue in Figure 2.2.
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Figure 2.7: Ribbons View of the low matching residue side chains on AtDEF2. The
side chains represent the low matching residues found in plantDEF2 when compared to the residues in
plantDEF1. The labels represent the conserved residues in plantDEF2 and the majority residues of
plantDEF1 are in parentheses.

2.3.2 Comparison between plantDEF2 and bacteriaDEF2
The three motifs of plantDEF2 were compared with the three motifs of
bacteriaDEF2. Again, we wanted to see if we could find residues that were conserved in
plantDEF2 that were not conserved and not the majority residue in bacteriaDEF2 in order
to be able to identify residues that could be used for inhibitor design. Table 2.2 shows
this comparison where the red X’s indicate the low match (20% or less) between
plantDEF2’s conserved residues and bacteriaDEF2’s corresponding residues.
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Table 2.2: plantDEF2 vs. bacteriaDEF2. The three motifs of both enzyme’s are compared
where the red X indicates conserved residues in plantDEF2 and the corresponding low matching (20% or
less) residue in bacteriaDEF2, whether or not it was conserved.
plantDEF2 vs. bacteriaDEF2
Motif 1: 119-133 (AtDEF2 numbers)
EcoliDEF2 residue #
41
AtDEF2 residue#
119
Conserved DEF2 Residue (50% or higher)
T
Majority Residue in bacteriaDEF2 Motif
A(43/99)
Number of bacteria Residues that Matched DEF2 T(2/99)
Low Match(20% or less) b/w Bacteria and DEF2 X

42
120

43
121

53
54
55
131
132
133
D
G
I
G
L
S
A
P
Q
V
G
L(n.c.) N
V
R(26/99) G(94/100) V(59/100)G(97/100)L(85/100)A(92/100)A(97/100)P(57/100)Q(94/100)V(45/100)G(70/100)V(31/100)S(27/100)K(41/100)
D(16/99) G(94/100) I(33/100) G(97/100)L(85/100)S(1/100) A(97/100)P(57/100)Q(94/100)V(45/100)G(70/100)L(14/100)N(6/100) V(6/100)
NC
X
X
X
X

Motif 2: 165-178 (AtDEF2 numbers)
EcoliDEF2 residue #
84
AtDEF2 residue#
165
Conserved DEF2 Residue (50% or higher)
V(n.c.)
Majority Residue in bacterialDEF2 Motif
L(21/99)
Number of bacteria Residues that Matched DEF2 V(9/99)
Low Match(20% or less) b/w Bacteria and DEF2 NC

85
166
P(n.c.)
T(22/99)
P(5/99)
NC

86
167

44
122

45
123

46
124

47
125

48
126

49
127

50
128

51
129

52
130

87
88
89
90
91
92
93
94
95
96
97
168
169
170
171
172
173
174
175
176
177
178
F
D(n.c.) E
G
C
L
S
F
P
G
I
Y
G(19/99) G(23/100)E(100) G(99/100)C(92/100)L(90/100)S(98/100)V(47/100)P(76/100)G(43/00)V(32/100)Y(31/100)
F(9/99) D(3/100) E(100) G(99/100)C(92/100)L(90/100)S(98/100)F(9/100) P(76/100)G(43/00)I(11/100)Y(31/100)
NC
X
X
X

Motif 3: 205-219 (AtDEF2 numbers)
EcoliDEF2 residue#
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
AtDEF2 residue#
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
Conserved DEF2 Residue (50% or higher)
S(n.c.) L
P
A
R
I(n.c.) F
Q
H
E
Y(n.c.) D
H
L
E(n.c.)
Majority Residue in Bacteria Motif
G(75/100) L(36/100) L(44/100) A(90/100)R(46/100)V(37/100)I(43/100)Q(90/100)H(100) E(97/100)I(46/100)D(95/100)H(92/100)L(86/100)N(48/100)
Number of bacteria Residues that Matched DEF2 S(3/100) L(36/100) P(15/100) A(90/100)R(46/100)I(11/100)F(14/100)Q(90/100)H(100) E(97/100)Y(7/100) D(95/100)H(92/100)L(86/100)E(7/100)
Low Match(20% or less) b/w Bacteria and DEF2 NC
NC
NC
NC
X
X
Note: The 'NC' and 'n.c.' in the charts above refer to non-conservation between the AtDEF2 sequence versus the other DEF2 plant sequences.

One can see there are 10 residues that were conserved in plantDEF2 that hardly showed
up in the database screening for plantDEF1 residues. These specific residues are of keen
interest because they represent consistent differences between the two enzymes. Figures
2.8 (molecular surface) and 2.9 (ribbons) show a pictorial representation of the low
matching residues on the AtDEF2 structure.
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Figure 2.8: Low matching residues on AtDEF2. The red represents the low matching residues
found in plantDEF2 when compared to the residues in bacteriaDEF2. Both red and blue represent the
originally conserved residues found in AtDEF2, which were shown as all blue in Figure 2.2.
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Figure 2.9: Ribbons View of the low matching residues’ side chains on AtDEF2. The
side chains represent the low matching residues found in plantDEF2 when compared to the residues in
bacteriaDEF2. The labels represent the conserved residues in plantDEF2 and the majority residues of
bacteriaDEF2 are in parentheses.

2.4 plantDEF2 Non-Conserved Residues Investigation
In order to make sure there were no residues in the three motifs of plantDEF2 that
were not being taken full advantage of, a non-conserved analysis was performed. This
involved checking what the next two highest residues were in plantDEF2 for that
particular position against the two majority residues for bacteriaDEF2. If a residue
showed up in many plantDEF2 sequences, but was not conserved, it still might be useful
as long as it also didn’t show up in many bacteriaDEF2 sequences (Table 2.3).
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Table 2.3: Investigation into the Non-Conserved Residues of plantDEF2 as
Compared to bacteriaDEF2. At the top of the chart are portions of the three motifs of plantDEF2.
There it can be seen which residues are the non-conserved (n.c.) ones. At the bottom of the chart are the
bacteriaDEF2 1st and 2nd majority residues as well as the residues that are found in bacteriaDEF2 that
matched the conserved plantDEF2 residues. From this diagram it can be inferred that the residues that
come up most often in place of the non-conserved residues of plantDEF2 are also virtually the same as the
majority residues found in bacteriaDEF2.
Low Matching Residues From plantDEF2

RES

Motif 1: 119-133
119
120

125 131 (n.c.)

132

Motif 2:165-178
133 165 (n.c.) 166 (n.c.)

167 168 (n.c.)

Motif 3: 205-219
177 205 (n.c.)
207 210 (n.c.)

174

42
42
43
44
44
44
43
43
42
43
42
#
T
D
S
L
N
V
V
P
F
D
F
A
1
1
1
C
D
1
41
1
4
E
4
18
F
28
42
G
1
H
I
17
6
2
K
L
3
6
13
M
8
N
43
17
P
15
Q
R
4
S
42
1
3
1
T
40
7
3
V
16
44
13
12
W
Y
13
Bacteria
41
42
47
53
54
55
84
85
86
87
93
Maj1
A(43/99) R(26/99) A(92/100) V(31/100) S(27/100) K(41/100) L(21/99) T(22/99) G(19/99) G(23/100) V(47/100)
Maj2
L(18/99) P(20/99) T(4/100) I(30/100) P(21/100) L(29/100) I,Q(11/99) S(18/99) Y(17/99) E(22/100) I(30/100)
Def2
T(2/99) D(16/99) S(1/100) L(14/100) N(6/100) V(6/100) V(9/99) P(5/99) F(9/99) D(3/100) F(9/100)

40
I

36
S

36
P

211 215 (n.c.) 219 (n.c.)

36
I

36
F

35
Y

32
E

3
7
4

6
1

36

26

15
1
39

14
1

1

3
2
24
1
5
1

21
2

6

1

1

21

9
96
124
126
129
130
134
138
V(32/100) G(75/100) L(44/100) V(37/100) I(43/100) I(46/100) N(48/100)
Y(16/100) D(11/100) P(15/100) C(33/100) V(20/100) M(15/100) D(22/100)
I(11/100) S(3/100) P(15/100) I(11/100) F(14/100) Y(7/100) E(7/100)

This analysis shows that the residues that come up most often in place of the nonconserved residues of plantDEF2 are also virtually the same as the majority residues
found in bacteriaDEF2. This means they can not be taken advantage of to try and further
find differences between the two for inhibitor selectivity purposes.

2.5 Modeling the Preferred D1 Substrate into an AtDEF2 Model
To get an idea of the possible interactions the preferred D1 substrate might
encounter in the AtDEF2 enzyme, we modeled in a generic MTAIL sequence molecule
based on a formyl-Met-Ala-Ser ligand alignment found in the protein data base (figure
2.10).46 It is important to note that bacterial enzyme conformations did not change much
whether a ligand was bound or not. This logic was applied to this study where an
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unbounded AtDEF2 enzyme was overlapped with a bacteriaDEF2 enzyme that already
had a tripeptide bound in order to get a general idea of MTAIL interactions. Doing this
would allow us an idea, at least near the active site, of any low matching residues of
plantDEF2 that might interact directly with the D1 substrate.

Figure 2.10: A ribbons view of AtDEF2 with a generic MTAIL (D1) peptide
inserted. From this generic diagram it can be hypothesized that the tyrosine residue at 178 might have
an H-bonding interaction with the threonine hydroxyl group of the D1 substrate. This might be something
that can be taken advantage of when trying to design an AtDEF2 specific inhibitor.

From this generic diagram, it can be hypothesized that the tyrosine residue at 178
might have an H-bonding interaction with the threonine hydroxyl group of the D1
substrate. This interaction might be one of the reasons why plantDEF2 prefers the D1
substrate. In order to understand the low matching residue interactions with the D1
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substrate better, a molecular dynamics experiment would need to be performed. This
would allow one an idea of what the energy minimized binding of the D1 substrate might
look and act like and tell us more specifically of any particular residues that influence this
process more than others. Current research being done at the time of writing involves the
running of molecular dynamics experiments with all of the enzyme’s atoms fixed and
with them moving freely. Other research being performed at the time of writing was a
mutagenesis experiment. This experiment replaces that specific residue in plantDEF2
and it might be possible to determine the direct relevance of that particular residue.

Copyright © Jonathan C. Barnes 2006
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Chapter 3: Design, Synthesis, and Purification of PDF Inhibitors
3.1 Synthesis of a Known Thiol Inhibitor
When I first started this project, I was asked if I could synthesize one of Pei’s
inhibitors 29b (Scheme 3.1), which was mentioned in the introductory chapter.32 The
purpose of this exercise was to be able to test a novel thiol inhibitor against plant PDF to
see how effective it would be. More specifically, to see if Pei’s most potent thiol
inhibitor would be more effective than actinonin (1) during in vivo leaf painting studies.
The following represents that synthesis (scheme 3.1).
The synthesis of the chelating portion of the thiol inhibitor32 started with a fairly
trivial butylation of dimethyl malonate 21 (69%) followed by hydrolysis to form malonic
acid 23. From there, paraformaldehyde and dimethylamine were used along with
refluxing to induce decarboxylation and form the α,ß-unsaturated acid 24 (63% over two
steps). For the final step in creating the chelating portion, thiolacetic acid was added to
the acid 24 to give the acetyl-protected thiol acid 25 via conjugate addition.
The synthesis of the remaining backbone portion involved the coupling of pnitroaniline with the N-Fmoc(fluorenylmethyloxycarbonyl)-protected acid 26b using
phosphorus oxychloride, imidazole, and pyridine. This product was then deprotected
with a 20% piperidine/dichloromethane solution to yield the coupled amine 27b (60%
yield over two steps).
Next, the two portions were coupled using dicyclohexylcarbodiimide (DCC) to
give the protected thiol 28b (92%). Next, the protected thiol 28b was reduced using
sodium borohydride in ethanol. This product was quenched with water and 5% HCl and
worked up and carried over to the next reaction with no chromatography. Finally, the NBoc group was removed using trifluoracetic acid (TFA) in dichloromethane to give the
final desired product 29b (74% over two steps).
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Scheme 3.1: Synthesis of a Potent Thiol Inhibitor 29b.32
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3.2 Design, Synthesis, and Purification of a Novel Thiol-Actinonin Chimera
34
The design and synthesis of the peptide-based inhibitors were conceived and
performed in concert with the computational active site analysis. This synthesis was
followed with purification and biological analysis to determine the potency of the
inhibitor, which is discussed later in chapter 4.

3.2.1 Design of a Novel Thiol-Actinonin Chimera 34
Due to the efficacy of actinonin 1 during in vitro studies (E. coli Ni-PDF: IC50 = 3
nM, MIC = 25 nM, KI = 0.28 nM)20 (AtDEF2 Ni-PDF: IC50 = 50-100 nM, MIC = 25
nM)23 and its inefficiency during in vivo studies26, it was proposed that the hydroxamate
chelating group responsible for metabolism of the inhibitor be removed altogether.
Through the accomplishments of Pei et al. 32 it was believed that thiol inhibitors could
survive in vivo and also prove to be fairly potent. Therefore, the design for our first
novel inhibitor was envisaged to possess the peptide backbone of actinonin and the
chelating thiol group from Pei’s most potent inhibitor 29b (E. coli Ni-PDF: MIC = 75100 μM, KI = 19 nM)32 (Figure 3.1).
Pei's Thiol Chelating Portion

O
NO2

H
N

N
N
H
O

O
OH

NH

O

1

HO

SH

NH
O

29b

NH2

Actinonin Backbone Portion
(A)

(B)

Figure 3.1: Structural Comparison between Actinonin (A) 1 and Pei’s Thiol
Inhibitor (B) 29b.
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This combination of the two portions might allow for a tight binding to the
AtDEF2 active site due to the side chains of actinonin and the chelating group found in
Pei’s thiol inhibitors. The result would be a novel actinonin chimera 34 (figure 3.2).

O
H
N

N

SH

N
H
O

O

HO

H2N

Figure 3.2: Thiol-Actinonin Chimera 34.

3.2.2 Synthesis of a Novel Thiol-Actinonin Chimera 34
The synthesis of 34 begins with L-prolinol (7) (scheme 3.2). L-prolinol (7) was
coupled with N-benzyloxycarbonyl-L-valine p-nitrophenylester (8) at room temperature
to give the N-CBZ (benzyloxycarbonyl)-protected amine 9 in nearly quantitative yields.15
Anderson’s route for the next step involves a reduction using 10% palladium-charcoal
and thermal decarboxylation, which forms a carbamic acid intermediate, whereas I
preferred the easier route using 10% Pd/C and a high pressure bomb hydrogenator with
~350-500 psi H2 to deprotect the N-CBZ group to form the primary amine 2 (96%).
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Scheme 3.2: Synthesis of L-Valyl-L-Prolinol (2) Used to Make the Actinonin
Chimera 34.
O
HN
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O2 N

NH

N

NH
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(S)

8
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O

EtOAc, rt

O

O

9, 99%
EtO

HO

HO

6

7, 35%

10% Pd/C
~350-500 psi H2

NH2
N

O

2, 96%
HO

Once the primary amine 2 had been synthesized, it was coupled to N-Fmoc-LLys(Boc)-OH (30) using DCC in dichloromethane, instead of using Pei’s route of using
POCl3/imidazole in pyridine seen in schemes 1.7, 3.1. This reaction step formed the NFmoc/Boc-protected chimera backbone product 31 (Scheme 3.3). Compound 31 was
then deprotected with DMAP in DMF to give the primary amine 32. Pei’s synthesis32
accomplished a similar deprotection by using a 20% piperidine solution in
dichlormethane. However, this did not produce adequate yields for this particular
reaction and was therefore changed to a 10% solution of DMAP, which produced the
primary amine 32 with little to no starting material observed on the thin layer
chromatography (TLC) plates. Product 32 was carried over with excess DMAP into the
next reaction, which involved a coupling between compound 32 and the acetyl-protected
thiol acid 25 using DCC in dichloromethane once again. This reaction yielded the final
coupling product 33 (50% over two steps) (Scheme 3.3).
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Scheme 3.3: Synthesis of Acetyl-Protected Thiol Inhibitor 33.
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The final two reactions performed on compound 33 involved a reduction of the Sacetyl group to form the sulfhydryl group and the removal of the Boc group, leaving the
primary amine 34 as the result (scheme 3.4). The reduction was a straightforward
reaction using sodium borohydride (NaBH4) in EtOH, while the trifluoracetic acid (TFA)
in CH2Cl2 was also a fairly trivial reaction that removes the N-Boc group.
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Scheme 3.4: Synthesis of the Thiol-Actinonin Chimera 34.
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3.2.3 Characterization and Purification of a Novel Thiol-Actinonin
Chimera 34
Characterization and purification of the thiol-actinonin chimera 34 was difficult
mainly for two reasons. Firstly, several deprotection steps along the way removed much
mass causing one to have to push through several grams of material in order to have a
decent amount of material at the end of the synthesis. Secondly, due to the polar nature
and the slow rotation about to the L-prolinol amide bond, the compounds throughout the
synthesis were hard to isolate and characterize. The second reason is the subject of this
subsection.
The rotation about the bond between the nitrogen of the L-prolinol group and the
adjacent carbon atom of the carbonyl functional group greatly affected the 1H and 13C
NMR spectra. Rotation causes less intense peaks to appear very closely in chemical shift
to the expected peaks for each product. This occurs because the rotation about the N-C
bond is a slow interconversion between rotamers that are approximately equal in energy,
but have slightly differing chemical shifts. The effect on the proton spectra was the
formation of many multiplets, while the carbon spectra (figures 3.3 and 3.4) showed
peaks that were smaller in height and adjacent to the predominant signal peaks. This
effect, in combination with the number of protons and carbons associated with each
compound throughout the synthesis, caused a great deal of complexity in the NMR
analysis. In order to try and alleviate this problem, the NMR solvent used was switched
from the usual CDCl3 and d-acetone to d6-dimethylsulfoxide (d6-DMSO) and the NMR
spectra were taken at 50 °C in order to increase the rate of rotation so that the signals
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averaged out and gave one main signal. In order to obtain better proton spectra, the NMR
tube could be heated to 100 °C, which would give a finer, more resolved peak instead of
a broad multiplet. This increase in temperature to 100 °C has yet to be performed at the
time of writing. The mass spectrometry (MS) and reverse-phase high pressure liquid
chromatography (RP-HPLC) data also helped support the otherwise qualitative NMR
analysis.

Figure 3.3: Full, Intensified 13CNMR of 34. Note the three amido-carbonyl peaks in the 170
ppm range.
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Figure 3.4: Closer view of the three amido-carbonyl peaks of 34 13CNMR. Note the
two-thirds less intense peaks to the right of each labeled peak. The chemical shift labels are in ppm.

The purification of most of the compounds along the line of the synthesis was
done mostly via flash chromatography, and the last compound, 34, was purified via RPHPLC. The biggest problem encountered when using flash chromatography was that the
retention factors (Rf) of the desired products were often very close to the byproducts’ Rf
values. There were three ways to solve this problem. Firstly, one could reduce the
amount of material per reaction in order to run smaller columns, which would allow
better resolution between product bands that would be emitted. The problem with this
idea, as mentioned earlier, is that one had to use many grams of material to obtain
relatively little amounts of product. Secondly, one could run fairly large columns with a
very “slow” solvent system (low polarity solvent system), which can be time consuming.
Thirdly, after characterization of products along the way, one could skip some
chromatographic sessions and simply carry the material on to the next step, so long as the
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product spot was interpretable via TLC. The latter two methodologies were employed
during the course of the synthesis of the compounds leading up to 34.
The purification of 34 to obtain the product diastereomers 34a and 34b was
performed using a reverse-phase C-18 HPLC column with a standard gradient of
acetonitrile (0-100%) in 0.1% aq. TFA. The absorbance was monitored at 214 nm. At
first, the diastereomers were separated into diastereomer 1 and diastereomer 2 +
byproduct (third major peak), but after performing the enzyme assays, which are
discussed in chapter 4, it was determined that there was no need to isolate the individual
diastereomers because there was not a great difference in potency observed. Therefore
the two major peaks of the reaction were collected together with approximately 80-85%
purity and characterized via 1H and 13C NMR as well as with +EI-MS and determined to
be the two diastereomers of the desired product 34.

3.3 Experimental Section
HPLC Solutions and Instrumentation
The purification of 34 was performed using a reverse-phase C-18 HPLC column
(Prep Scale: VYDAC, Protein and Peptide C18; Analytical Scale: Aquapore, Butyl 7
micron, 220 x 4.6 mm) with a standard 50-minute gradient of acetonitrile (0-100%) in
0.1% aq. TFA at10ml min-1. The absorbance was monitored at 214 nm and the
diastereomers collected. The other instruments used in conjunction with the column were
a Waters 510 HPLC pump, Waters U6K Millipore, and a Waters Tunable Abs. Detector.

Synthesis/Characterization Procedures/Results
For all of the compounds reported, the 400 MHz 1H NMR and 100 MHz 13C
NMR data were collected on a Varian VXR-400S. For all pH values reported, a Denver
Instrument pH Meter was used.
The Mass Spectrometry data was obtained by Dr. Jack Goodman of the
University of Kentucky Mass Spectrometry Facility. Electron impact (EI) ionization
mass spectra were recorded at 70eV on ThermoFinnigan PolarisQ (ion trap mass
spectrometer). Samples were introduced via heatable direct probe inlet. Electrospray
ionization (ESI) mass spectra were obtained on a ThermoFinnigan LTQ.
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MeO

OMe

O

32

Dimethyl 2-butylmalonate (22a).

O

C9H16O4. Na metal (2.02 g, 88.0 mmol) was added

to dry MeOH (~100 mL) under N2 at 0 °C. Next, dimethyl malonate (5.02 mL, 44.0
mmol) was added to the reaction mix and stirred for ~ 30 minutes while warming to room
temperature. Then, 1-iodobutane (3.41 mL, 30.0 mmol) was added to the reaction mix
via cannula from a separate reaction flask also under N2 and containing MeOH (~50 mL).
The reaction was allowed to reflux for 30 minutes, and then the solvent was evaporated
and the residue worked up using +NH4 -Cl and ether. The organic portion was dried with
MgSO4 and filtered. Flash chromatography (10% ethyl acetate in petroleum ether) gave
pure 22a (69% yield). 1H NMR (400 MHz, CDCl3) :st, 7.51 Hz,
1H), 1.88-1.94 (m, 2H), 1.24-1.39 (m, 4H), 0.90 (t, 7.05 Hz, 3H).

13

C NMR (100 MHz,

CDCl3) 

OH

O

2-(n-Butyl)-acrylic acid (24).32 C7H12O2. Dimethyl 2-butylmalonate (22a) (1.0 g, 5.3
mmol) was dissolved in a H2O/MeOH (15 mL of each) solution and NaOH (466 mg,
11.66 mmol) was added and the solution refluxed for ~ 1hr. The flask was cooled to
room temperature and the reaction mixture diluted with H2O (30 mL) and extracted with
ethyl acetate (30 mL). The aqueous layer was cooled to 0°C and made to have a pH of 1
via the addition of conc. HCl. The solution was then extracted with ethyl acetate (3 x 20
mL portions) and the combined organic layers were dried via MgSO4, and the solvent
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evaporated. The white solid formed 23 was carried over to the next step without flash
chromatography, nor NMR analysis. The white solid 23 was dissolved in EtOAc (20
mL), cooled to 0°C. Next, dimethyl amine (752 μl, 15.0 mmol) and paraformaldehyde
(300 mg, 10.0 mmol) were added to the reaction mixture and allowed to stir at room
temperature for 10 minutes. Then, the reaction was refluxed for 2 hrs. Next, the reaction
was cooled to room temperature and quenched with H2O (30 mL). The solution was
cooled to 0°C and conc. HCl was added to make the pH equal to 1. After extraction with
ethyl acetate (3 x 30 mL portions), the organic layer was dried with MgSO4 and the
solvent evaporated to obtain pure 24 (63% yield over two steps). 1H NMR (200 MHz,
CDCl3) : 6.24 (s, 1H), 5.62 (s, 1H), 2.30 (t, 7.6 Hz, 2H), 1.23-1.57 (m, 4H), 0.92 (t, 7.0
Hz, 3H).

13

C NMR (100 MHz, CDCl3) : 173.2, 140.4, 127.4, 31.3, 30.7, 22.5, 14.1.

S

OH

O

O

32

3-Acetylmercapto-2-butylpropionic acid (25).

C9H16O3S. 2-(n-Butyl)-acrylic acid

(24) (396 mg, 3.09 mmol) was added to thiolacetic acid (330 μl, 4.64 mmol) and refluxed
for 2 hrs. Then, the excess thiolacetic acid was evaporated and the residue was dissolved
in NaHCO3 (20 mL) and extracted with ethyl acetate (2 x 40 mL portions). Next, the
aqueous layer was cooled to 0°C and acidified with HCl to pH 2.18 and extracted with
ethyl acetate (2 x 40 mL portions). The organic layer was dried with MgSO4 and
following flash chromatography (15% ethyl acetate in petroleum ether) the resultant
solvent was evaporated to give pure 25 (73% yield). 1H NMR (400 MHz, CDCl3) :
11.23 (broad s, 1H), 3.12-3.18 (dd, 5.31 Hz, 5.50 Hz, 1H), 2.99-3.06 (dd, 8.61 Hz, 8.79
Hz, 1H), 2.58-2.71 (m, 1H), 2.34 (s, 3H), 1.52-1.76 (m, 2H), 1.28-1.42 (m, 4H), 0.91 (t,
7.05 Hz, 3H).

13

C NMR (100 MHz, CDCl3) : 195.7, 180.6, 45.7, 31.5, 31.0, 29.9, 29.7,

22.7, 14.4.
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O
O
HN
N
O
HO

N-Benzyloxycarbonyl-L-valyl-L-prolinol (9). 15 C18H26N2O4. Z-Valine-O-nitrophenyl
ester (8) (5.45 g, 14.63 mmol) was dissolved in ethyl acetate (25 mL) and placed under
N2. Next, L-prolinol (7) (1.43 mL, 14.63 mmol) was added to the reaction mixture,
which was allowed to stir for 48 hrs. Then, chloroform (20 mL) was added and washed
with 2N HCl (20 mL). Next, it was washed with 2N NH4OH (3 x 20 mL portions) and
H2O (30 mL). The organic layer was dried with MgSO4 and the solvent evaporated to
give 9 (99% yield). 1H NMR (400 MHz, CDCl3) : 7.28-7.38 (m, 5H), 5.59 (d, 8.97 Hz,
1H), 5.00-5.14 (m, 2H), 4.22-4.46 (m, 4H), 3.80-3.89 (m, 1H), 3.45-3.71 (m, 3H), 1.812.10 (m, 4H), 1.55-1.64 (m, 1H), 1.03 (d, 6.78 Hz, 3H), 0.96 (d, 6.78 Hz, 3H).

13C

NMR

(100 MHz, CDCl3) : 173.3, 156.7, 136.5, 128.7, 128.3, 128.2, 67.2, 67.1, 58.0, 48.5,
31.7, 28.2, 24.7, 19.5, 17.8.
NH2
N

O
HO

L-Valyl-L-prolinol

(2). N-Benzyloxycarbonyl-L-valyl-L-prolinol (9) (3.308 g, 9.892

mmol) was dissolved in ethyl acetate (200 mL) and placed in a bomb hydrogenator with
Pd/C (10% wt., 300 mg) under H2 (425 psi) for 2 days. Filtered with Celite and flash
chromatography (5% MeOH/95% CH2Cl2/0.5% NH4OH) gave product 2 (96% yield).
1H

NMR (400 MHz, CDCl3) : 4.21-4.28 (m, 1H), 3.39-3.62 (m, 5H), 3.11 (d, 5.86 Hz,

1H), 2.44-2.54 (m, 1H), 1.70-2.40 (m, 4H), 1.52-1.60 (m, 1H), 0.975 (d, 6.23 Hz, 3H),
0.925 (s, 3H).

13C

NMR (100 MHz, CDCl3) : 176.8, 67.3, 62.7, 60.9, 47.9, 31.7, 27.9,
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24.0, 19.5, 18.3. +EI-GC-MS showed one predominant peak with a retention time of
10.41 minutes and 97% purity. The parent ion weight observed was 201 amu(100)
(desired product plus H+).

O
N

NHFmoc
N
H
O

HO

BocHN

N2-Fluorenylmethoxycarbonyl-L-(N6-Boc)-L-valyl-L-prolinol (31). C36H50N4O7. Lvalyl-L-prolinol (2) (2.048 g, 10.21 mmol) was dissolved in CH2Cl2 (80 mL). Next,
Fmoc-Lys(Boc)-OH (32) (4.784 g, 10.21 mmol) was added along with DCC (2.107 g,
10.21 mmol) all under N2 at room temperature. The solution was allowed to mix
overnight. Flash chromatography (3% MeOH/97% CH2Cl2) in a large column yielded
product 31 (82% yield). 1H NMR (400 MHz, d6-acetone) : 7.85 (d, 7.51 Hz, 2H), 7.71
(t, 7.60 Hz, 2H), 7.42-7.52 (m, 1H), 7.41 (t, 7.50 Hz, 2H), 7.32 (t, 7.51 Hz, 2H), 4.524.71 (m, 1H), 4.21-4.37 (m, 4H), 4.10-4.18 (m, 1H), 3.68-3.87 (m, 1H), 3.40-3.64 (m,
3H), 2.98-3.12 (m, 2H), 2.88 (s, 3H), 1.64-2.09 (m, 11H), 1.39 (s, 9H), 0.93 (m, 6H).

13C

NMR (100 MHz, d6-DMSO, 50 °C) : 173.1, 157.1, 145.1, 144.9, 142.1, 128.6, 128.0,
126.2, 120.8, 78.3, 67.3, 65.1, 63.2, 56.4, 55.2, 48.1, 48.0, 47.9, 40.7, 32.1, 32.0, 28.8,
27.8, 25.2, 24.5, 23.8, 23.0, 20.3, 18.1.
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O
N

NH2
N
H
O

HO

BocHN

6

L-(N

-Boc)-L-valyl-L-prolinol (32). C21H40N4O5. N2-Fluorenylmethoxycarbonyl-L-(N6-

Boc)-L-valyl-L-prolinol (31) (1.00 g, 1.54 mmol) was dissolved in DMF (4.79 mL, 4.50
g) and DMAP (0.50 g, 4.1 mmol) was added all under N2 at room temperature. After 48
hrs., flash chromatography in a large silica column (flushed with 3 L petroleum ether,
then used 3%MeOH/97% CH2Cl2/few drops NH4OH) was employed to yield product 32
in low yield (30%). The purification was done for the purposes of NMR studies;
subsequent reaction attempts just carried the crude material on to the next step along with
excess DMAP without any flash chromatography. Qualitatively, the 1H NMR spectra
showed the absence of the Fmoc protons and carbons. 1H NMR (400 MHz, d6-acetone)
: 4.28-4.71 (m, 4H), 4.06-4.21 (m, 2H), 3.85-3.90 (m, 1H), 3.72-3.82 (m, 1H), 3.35-3.70
(m, 4H), 2.98-3.12 (m, 2H), 1.62-2.08 (m, 11H), 1.39 (s, 9H), 0.88-0.98 (m, 6H).

13C

NMR (100 MHz, d6-acetone) : 173.8, 172.5, 157.1, 78.7, 65.1, 61.2, 56.1, 56.0, 48.7,
41.4, 32.7, 31.4, 29.1, 28.4, 25.4, 24.1, 22.6, 20.4, 18.5.

O
H
N

N

S

N
H
O

O

O

HO

BocHN

2

L-N

-(3-Acetyl mercapto-2-butylpropionyl)-(N6-Boc)-L-valyl-L-prolinol (33).

C30H54N4O7S. L-(N6-Boc)-L-valyl-L-prolinol (32) (1.648 g, 3.850 mmol) was dissolved
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in CH2Cl2 (30 mL) and 3-acetylmercapto-2-butylpropionic acid (25) (0.7854 g, 3.850
mmol) and DCC (0.7944 g, 3.850 mmol) were added. The reaction mixture was placed
under N2 at room temperature. Flash chromatography ( 1 L diethyl ether flush, then 2%
MeOH/98% CH2Cl2/NH4OH in large silica column) produced product 33 (58% over 3
steps). 1H NMR (400 MHz, d6-DMSO, 50°C) : 3.79-4.72 (m, 6H), 3.30-3.52 (m, 3H),
3.02-3.22 (m, 3H), 2.69-2.90 (m, 6H), 2.27-2.55 (m, 3H), 2.20 (s, 3H), 1.60-1.93 (m,
6H), 1.32-1.59 (m, 4H), 1.28 (s, 9H), 1.04-1.19 (m, 5H), 0.68-0.81 (m, 6H).

13C

NMR

(100 MHz, d6-DMSO, 50 °C) : 173.0, 171.2, 169.6, 155.4, 77.2, 61.1, 58.4, 55.5, 46.8,
45.2, 40.2, 31.7, 31.5, 30.8, 30.3, 29.0, 28.5, 28.1, 23.5, 22.5, 21.9, 21.8, 18.9, 17.8, 13.5.
+ESI-MS showed 615 amu (100) (desired product plus H+).

O
H
N

N

SH

N
H
O

O

HO

H 2N

Thiol-Actinonin Chimera (34a + b). C23H44N4O4S. L-N2-(3-Acetyl mercapto-2butylpropionyl)-(N6-Boc)-L-valyl-L-prolinol (33) (960 mg, 1.56 mmol) was dissolved in
dry EtOH (25 mL) in a Schlenk flask under N2. Then, NaBH4 (500 mg, 12.5 mmol) was
added and the reaction mixed for ~24 hrs. Next, H2O (3 mL) and 5% HCl (1 mL) were
added to quench the reaction. The volatile solvents were evaporated and the residue was
dissolved in ethyl acetate (20 mL). This solution was washed with sat. NaCl (2 x 20 mL),
the organic layer was dried via MgSO4, and the resultant solvent evaporated. This
product was carried directly over to the next step, which entailed dissolving the reaction
mixture in CH2Cl2 (45 mL) and then adding TFA (6.52 mL, 87.7 mmol) and allowing to
stir overnight under N2. Flash chromatography (initially used 3% MeOH/ 97%
CH2Cl2/NH4OH and gradually increased the volume of MeOH) and RP-HPLC (50-min
acetonitrile gradient (0-100%) in 0.1 % TFA aqueous solution; 28.49 min Rt for diast. 1,
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and Rt 29.46 min. for diast. 2) yielded the product diastereomers 34a + 34b. 1H NMR
(400 MHz, d6-DMSO, 50 °C) : 7.98-8.13 (m, 1H), 7.45-7.78 (m, 3H), 5.20-6.25 (broad
m, 6H), 4.15-4.69 (m, 2H), 3.73-4.03 (m, 1H), 3.42-3.67 (m, 1H), 3.18-3.35 (m, 1H),
2.38-2.80 (m, 6H), 1.62-2.20 (m, 6H), 1.14-1.60 (m, 7H), 0.78-0.93 (m, 6H).

13C

NMR

(100 MHz, d6-DMSO, 50 °C)

+EI-MS showed the highest molecular ion to be
473 amu (desired product plus H+).

Copyright © Jonathan C. Barnes 2006
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Chapter 4: Biological Analysis of Pei’s Inhibitor 29b and the Chimera 34
The following subsections deal with the leaf-painting experiments, seed
germination tests, and the enzyme assays performed on the chimera 34. Also, the
following subsections deal with the leaf-painting experiments and seed-germination tests
on Pei’s thiol inhibitor 29b. No enzyme assays were performed with Pei’s thiol inhibitor
29b. The preliminary results show the thiol-actinonin chimera to be an inhibitor of
AtDEF2 and a comparison of it’s potency to actinonin 1 and Pei’s inhibitor 29b it was
mimicked off of is given.

4.1 Seed Germination Analysis
Seed germination analysis was conducted on the two thiol inhibitors, Pei’s 29b
and the thiol-actinonin chimera 34. At the time of this experimentation, this batch of 34
inhibitor had NOT undergone RP-HPLC purification; it was still crude. The growth
medium for this experiment was comprised of a Murashige and Skoog salt mixture, agar,
100 X MES buffer solution (pH 5.6), and H2O. This growth medium was applied to the
test plates while still in viscous gel phase. The seeds used were either wild type (WT) or
pdf over-expressor (OE) tobacco seeds; both of which were sterilized prior to testing.
For 34, a 100 mM stock solution was made from which 20 μL (= 5mM final
concentration) was injected into 380 μL of growth medium in 18 test plate wells. The
first lane of six wells was OE seeds, while the second lane consisted of WT seeds, and
the third lane of six wells possessed WT seeds with no inhibitor. The result from this
seed germination test after 4 days was the OE seeds showed initial stages of cotyledon
growth, the WT-inhibitor seeds showed radical emergence, and the WT-no inhibitor
showed normal cotyledon growth. This seemed promising at first, especially considering
that the imhibitor material was crude, but after a week to 10 days most of the wells
showed medium to full cotyledon development (data not shown due to preliminary
experimentation with crude material; needs further tests). It could be inferred that the
inhibitor was somehow metabolized by the proteolytic enzymes found in vivo, but it is
hard to be certain when the material was crude. This experiment will be repeated with
the latest batch of purer chimera inhibitor diastereomers 34.
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Pei’s inhibitor 29b was also made into a 100 mM stock solution from which 20
μL (= 5mM final concentration) was injected into 380 μL of growth medium in 30 wells
of the test plate. The first two lanes (12 wells) contained a tobacco WT seed. The next
lane and a third (8 wells) contained tobacco OE seeds. The final lane (6 wells) contained
WT seeds with no inhibitor. The result of this seed germination test after 4 days-12 days
showed the complete inhibition of growth past radicale emergence (data not shown due to
preliminary experimentation; needs further tests).
4.2 Leaf-Painting Analysis
Leaf-painting analysis required making 10 mg/ mL solutions + 0.1% (v/v) Tween
20 (a detergent from Sigma, which helps the inhibitor cross the membrane) of each
inhibitor and applying 300 μL of the solution to the leaves of the plants over 6 days. An
additional solution was made for 29b due to the difficulty of dissolving the inhibitor in an
aqueous solution. This solution contained the usual 10 mg/mL of inhibitor as well as the
0.1% Tween 20, but also contained 0.5% acetone to help the inhibitor dissolve more
quickly and efficiently. Again, it is important to note that the same batch of inhibitor 34
that was used in the seed germination tests was also used in this line of experimentation,
meaning that it was crude.
The application of 34 to tobacco leafs in 300 μL + 0.1% Tween 20 portions daily.
The result of this experiment was the initial signs of bleaching of color after 1-2 days.
However, the bleaching that was observed quickly disappeared, and the experiment failed
to kill the plants (data not shown). This may be attributed to the inhibitor being degraded
by enzymes in vivo, or it might be related to a lower dose of the inhibitor actually being
used due to the crude nature of the material.
The two 29b solutions, one with 0.5% acetone and one without the acetone, were
applied to 2 tobacco plants each. Additionally, 1 pea plant that possessed two sets of true
leaves was treated with 29b, as well as 1 small pea plant without true leaves. After daily
applications of 300 μL of the inhibitor + 0.1% of Tween 20 solution, the result was a
stronger and more intense bleaching effect of the leaves than seen with 34. However, the
bleaching soon disappeared and the plants grew normally. This would indicate that the
plant may be metabolizing the thiol inhibitor 29b just as it did with actinonin (1). More
inhibitor would have to be synthesized and the experiments run again in conjunction with
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the new 34 experiments in order to clearly understand the implications of the
aforementioned outcome.

4.3 Enzyme Assays of 34a and 34b
Spectrophotometric enzyme assays23,47 of AtDEF2 activity were conducted at
room temperature (25 °C) with a pH 8 buffer solution containing 0.1 mM NiSO4,
methionine aminopeptidase (MAP, 1U/ μL) and using the thiol inhibitor diastereomers
34a and 34b (new batch, post RP-HPLC) and the enzyme substrate N-formyl-Met-Leu-pnitroaniline (f-ML-pNA). The release of the conjugated p-nitroaniline group was
measured by monitoring the absorbance increase at 405 nm. The data was charted on the
instrument computer as milli-Absorbance per minute (mAbs./min) in order of decreasing
activity with increasing inhibitor concentration. The results for 34a and 34b + byproduct
are tabulated in Tables 4.1 and 4.2, respectively, and figures 4.1 and 4.2 respectively.
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Table 4.1: 34a’s Effect on AtDEF2’s (Ni) Activity. For each assay, 0.62 μL of 1/10 NiAtDEF2 was used.
Run #

Inhibitor (conc. x

Slope (mAbs/min)

volume = moles)
1

100 μM 100 μL =

37.88

10000 nM
2

100 μM 80 μL =

118.8

8000 nM
3

100 μM 60 μL =

276.5

6000 nM
4

100 μM 40 μL =

526.5

4000 nM
5

100 μM 30 μL =

640.5

3000 nM
6

100 μM 15 μL =

652.5

1500 nM
7

100 μM 5 μL = 500

693.0

nM
Blank

No Inhibitor

801.9
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Figure 4.1: 34a: Inhbition of AtDEF2 (Ni) Activity.

The minimum inhibitory concentration (MIC) of 34a seen in Table 4.1 and Figure
4.1 is 500 nM. The 50% inhibitory concentration (IC50) of 34a is 5000 nM.
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Table 4.2: 34b + Byproduct’s Effect on AtDEF2’s (Ni) Activity. For each assay, 0.62
μL of 1/10 Ni-AtDEF2 was used.
Run #

Inhibitor (conc. x

Slope (mAbs/min)

volume = moles)
1

100 μM 100 μL =

5.98

10000 nM
2

100 μM 60 μL =

78.11

6000 nM
3

100 μM 30 μL =

201.0

3000 nM
4

100 μM 15 μL =

326.7

1500 nM
5

100 μM 5 μL = 500

451.1

nM
6

100 μM 2 μL = 200

587.0

nM
Blank

No Inhibitor

801.9
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Figure 4.2: 34b + Byproduct: Inhbition of AtDEF2 (Ni) Activity.

The minimum inhibitory concentration (MIC) of 34b + byproduct seen in Table
4.2 and Figure 4.2 is 200 nM. The 50% inhibitory concentration (IC50) of 34b =
byproduct is 1000 nM.
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Table 4.3: Comparison of the MIC and IC50 between Actinonin 1, Pei’s Thiol 29b,
and the Thiol-Actinonin Chimera 34a + b. Values are from literature or from
experimentation discussed above.20, 23, 32

Actinonin 1 (E coli Ni-

MIC

IC50

25.0 nM

3.0 nM

75-100 μM

N/A

500 nM

5000 nM

200 nM

1000 nM

PDF)
Pei’s Thiol 29b (E. coli: NiPDF)
Chimera 34a (AtDEF2: NiPDF)
Chimera 34b + byproduct
(AtDEF2: Ni-PDF)

Table 4.3 shows the MIC and IC50 values for each of the inhibitors discussed
throughout this thesis. It is important to first point out that the enzyme assays conducted
to obtain the data above were done with E. coli for 1 and 29b and with AtDEF2 for 34a
and 34b+byproduct. Actinonin is the most potent of the group with an MIC of 25.0 nM
and an IC50 of 3.0 nM for E. coli Ni-PDF. Compare that with the other extreme, Pei’s
thiol 29b, and it is evident the loss in potency is 3000 to 4000-fold. However, it is
interesting to point out that the chimeras 34a and 34b+byproduct show a much higher
potency than 29b by 150 to 250-fold and 375 to 500-fold, respectively. One is able to
extrapolate from the data presented in Table 4.3, even when considering the differing
hosts, the effect of changing the hydroxamate group on actinonin 1 to a sulfhydryl group
to make the chimera 34. The chimera 34a is 20 times less potent during in vitro enzyme
assays than actinonin and 34b + byproduct is only 8 times less potent. It would be
interesting to do the same Arabidopsis thaliana assays with 29b to see what the MIC and
IC50 are. Dirk et al.23 did the AtDEF2 assay with actinonin and observed an IC50 at 50100 nM, which is even closer in potency to the data for 34a and 34b + byproduct.
Therefore, we have shown that the thiol-actinonin chimera 34a or b is truly a
hybrid that favors more closely the characteristic potency observed with actinonin 1 than
with Pei’s thiol inhibitor 29b.
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Even though 34b has an equal amount of byproduct present, it still did not show
any substantial potency difference from the much more pure diastereomer 34a. Hence,
the two were kept together for the purposes of NMR and MS data experiments. The next
enzyme assay should involve the use of a mixture of the diastereomers since they have
the same activity.
Methionine aminopeptidase assays were also conducted to determine if the
inhibitor had any effect on the particular enzyme using a different substrate (no N-formyl,
rather start with methionine). At high, or low, concentrations of 34, 6000nM and 1000
nM of either diastereomer, the enzyme methionine aminopeptidase showed high activity
as evidenced by the 8382 and 9291 mAbs/min slope, respectively. Therefore, the
inhibitor diastereomers 34a+b were not a factor in MAP inhibition.

4.4 Experimental Section
Seed Germination Tests.
I imbibed Tobacco seeds (wild type [WT] and over expresser [OE]) and the
seedlings were cultured at room temperature with constant light (50 μmol m-2s-1) in a 1%
agar/380 μl Murashige and Skoog basal salts (Sigma) medium in the wells of a 96-well
microtiter. The cultures were done either in the absence or presence of either of the thiol
inhibitors, 29b and 34.

Leaf-Painting Analysis.
10 mg/ml + 0.1% Tween 20 aqueous solutions of both thiol inhibitors were
comprised. These solution mixtures were then applied to tobacco and pea plants of
various maturity and growth in 300 μL volumes on a daily basis. Observations were
made visually based on discoloration and bleaching.

Enzyme Assays.
Spectrophotometric assays of AtDEF2 activity23,47 were conducted at 25 °C in
polystyrene cuvettes containing 885-985 μL of pH 8 buffer with 0.1 mM NiSO4, with 1
unit of Aeromonas proteolytica methionine aminopeptidase (MAP, 1U/ μL; Sigma, St.
Louis) and 2-100 μL of 100 μM of thiol inhibitor diastereomers 34a+b (new batch, post
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RP-HPLC) and 10 μL of 20 mM of the enzyme substrate N-formyl-Met-Leu-pnitroaniline (f-ML-pNA substrate was the initiator of the assay, BACHEM Bioscience
Inc., King of Prussia, PA). The release of p-nitroaniline was measured by monitoring the
increase in absorbance at 405 nm using a UV-201 PC scanning spectrophotometer
(Shimadzu Scientific Instruments, Inc., Columbia, MD).

Copyright © Jonathan C. Barnes 2006
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Chapter 5: Conclusion
The enzyme peptide deformylase (PDF) is responsible for the removal of the
formyl group located at the N-terminus of nascent proteins in order for them to become
mature, functioning proteins. It exists in prokaryotic and eukaryotic forms, in bacteria,
chloroplasts, and mitochondria. However, only in bacteria and plants has it been shown
that proteins require the removal of the formyl group post-translation in order to function
properly. PDF has been studied extensively, as evidenced by the vast number of articles
published yearly on the subject, and has been shown to be a mononuclear
metalloprotease. Because metalloproteases are so widely studied and are the best-known
form of enzymes, PDF is a target for the antibiotics and herbicidal industry. It has even
been proposed to be viable for use as a selectable marker. A selectable marker is a
genetically engineered reporter gene that indicates whether or not a successful transfer of
foreign DNA into a cell was made by growing the target in an environment laden with
PDF inhibitor. The colonies that survive the inhibitor medium have taken up and
expressed the injected foreign DNA.
Over the past 4 decades, many scientists have tried to design and synthesize
inhibitors of PDF in order to create the next new antibiotic, or herbicide. The best
naturally known in vitro inhibitor of PDF is actinonin. The biggest problems with
actinonin are that it is too expensive to purchase on a massive scale, and it is too easily
metabolized in vivo. Therefore, several attempts at making analogues of the
hydroxamate inhibitor have been made, to not much avail. The next generation of
inhibitors specifically designed to inhibit PDF was created by Dr. Pei at Ohio State
University. These inhibitors showed potency, but eventually experienced a similar in
vivo problem as actinonin. The compound I designed and synthesized seems to suffer
from the same drawback. There still needs to be work done in order to solidify this
preliminary observation. The last generation of inhibitors, the macrocyclic reversehydroxamate inhibitors also created by Dr. Pei, seem to be working well as far as potency
and in vivo survival are concerned. However, as of this date, there are no articles
describing the ability of these macrocyclic inhibitors to inhibit plant PDF. It would be
interesting to determine the efficacy of the macrocyclic inhibitors.
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There were many goals to be accomplished and that were accomplished
throughout the course of my research. The first goal consisted of modeling and analyzing
the three different types of active sites of PDF; AtDEF1, AtDEF2, and EcoliDEF2. Most
importantly for the scope of my project was the AtDEF2 due to its location in the
thylakoid membrane of chloroplasts and its 100-fold higher activity than AtDEF1. In the
midst of the analysis of the different active sites, several residues were found to be fairly
consistently different between AtDEF1 and 2 and between AtDEF2 and EcoliDEF2. This
is important because in order for a designed inhibitor to be selective towards plant PDF
versus bacterial PDF, there must exist a difference between the types of PDF; more
specifically between AtDEF2 and EcoliDEF2. With the further work soon to be
accomplished on the molecular dynamics front, we should have a better idea just how
important those differing residues really are and how well the AtDEF2 preferred D1
substrate binds to the active site and why it is not preferred by AtDEF1.
The second goal was to synthesize a peptide-based thiol inhibitor designed by Pei
and synthesize one that mimicked actinonin 1 in regards to the backbone and a sulfhydryl
in regards to the chelating portion of the compound. Both of these synthetic goals were
accomplished, and the purity of the resulting chimera is the best it’s ever been. It is good
enough right now to run new leaf-painting analyses and seed germination tests to see how
potent the diastereomeric mixture of the inhibitor 34 truly is. The enzyme assays showed
that it does in fact inhibit AtDEF2, albeit not as intensely as actinonin, but close. It was
more potent than Pei’s thiol 29b and upon further experiments, might survive in vivo
tests where actinonin failed. It is difficult to conclude at this juncture if the chimera 34 is
being metabolized based on the crude material that was used to conduct the analyses.
In closing, we have found many consistent differences between the three types of
PDF enzymes, synthesized a novel thiol-actinonin chimera 34, begun new syntheses of
D1 substrate mimics, and tested the biological efficacy of said inhibitors in crude form,
and will retest the more pure form of each to determine the true PDF inhibitory prowess
they may possess.

Copyright © Jonathan C. Barnes 2006
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